Hanrahan EO - Search Results

1

Randomized trial of high-dose chemotherapy and autologous hematopoietic stem cell support for high-risk primary breast carcinoma: follow-up at 12 years.

Hanrahan EO, Broglio K, Frye D, Buzdar AU, Theriault RL, Valero V, Booser DJ, Singletary SE, Strom EA, Gajewski JL, Champlin RE, Hortobagyi GN. Hanrahan EO, et al. Cancer. 2006 Jun 1;106(11):2327-36. doi: 10.1002/cncr.21906. Cancer. 2006. PMID: 16639731 Free article. Clinical Trial.

2

Combined-modality treatment for isolated recurrences of breast carcinoma: update on 30 years of experience at the University of Texas M.D. Anderson Cancer Center and assessment of prognostic factors.

Hanrahan EO, Broglio KR, Buzdar AU, Theriault RL, Valero V, Cristofanilli M, Yin G, Kau SW, Hortobagyi GN, Rivera E. Hanrahan EO, et al. Cancer. 2005 Sep 15;104(6):1158-71. doi: 10.1002/cncr.21305. Cancer. 2005. PMID: 16047352 Free article.

3

Neoadjuvant systemic therapy for breast cancer: an overview and review of recent clinical trials.

Hanrahan EO, Hennessy BT, Valero V. Hanrahan EO, et al. Expert Opin Pharmacother. 2005 Aug;6(9):1477-91. doi: 10.1517/14656566.6.9.1477. Expert Opin Pharmacother. 2005. PMID: 16086636 Review.

4

Prognosis and management of patients with node-negative invasive breast carcinoma that is 1 cm or smaller in size (stage 1; T1a,bN0M0): a review of the literature.

Hanrahan EO, Valero V, Gonzalez-Angulo AM, Hortobagyi GN. Hanrahan EO, et al. J Clin Oncol. 2006 May 1;24(13):2113-22. doi: 10.1200/JCO.2005.02.8035. J Clin Oncol. 2006. PMID: 16648513 Review.

5

Low number of examined lymph nodes in node-negative breast cancer patients is an adverse prognostic factor.

Blancas I, García-Puche JL, Bermejo B, Hanrahan EO, Monteagudo C, Martínez-Agulló A, Rouzier R, Hennessy BT, Valero V, Lluch A. Blancas I, et al. Among authors: hanrahan eo. Ann Oncol. 2006 Nov;17(11):1644-9. doi: 10.1093/annonc/mdl169. Epub 2006 Jul 27. Ann Oncol. 2006. PMID: 16873428 Free article.

6

Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma.

Hanrahan EO, Gonzalez-Angulo AM, Giordano SH, Rouzier R, Broglio KR, Hortobagyi GN, Valero V. Hanrahan EO, et al. J Clin Oncol. 2007 Nov 1;25(31):4952-60. doi: 10.1200/JCO.2006.08.0499. J Clin Oncol. 2007. PMID: 17971593

7

Baseline vascular endothelial growth factor concentration as a potential predictive marker of benefit from vandetanib in non-small cell lung cancer.

Hanrahan EO, Ryan AJ, Mann H, Kennedy SJ, Langmuir P, Natale RB, Herbst RS, Johnson BE, Heymach JV. Hanrahan EO, et al. Clin Cancer Res. 2009 May 15;15(10):3600-9. doi: 10.1158/1078-0432.CCR-08-2568. Epub 2009 May 15. Clin Cancer Res. 2009. PMID: 19447868

8

High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller.

Gonzalez-Angulo AM, Litton JK, Broglio KR, Meric-Bernstam F, Rakkhit R, Cardoso F, Peintinger F, Hanrahan EO, Sahin A, Guray M, Larsimont D, Feoli F, Stranzl H, Buchholz TA, Valero V, Theriault R, Piccart-Gebhart M, Ravdin PM, Berry DA, Hortobagyi GN. Gonzalez-Angulo AM, et al. Among authors: hanrahan eo. J Clin Oncol. 2009 Dec 1;27(34):5700-6. doi: 10.1200/JCO.2009.23.2025. Epub 2009 Nov 2. J Clin Oncol. 2009. PMID: 19884543 Free PMC article.

9

Distinct patterns of cytokine and angiogenic factor modulation and markers of benefit for vandetanib and/or chemotherapy in patients with non-small-cell lung cancer.

Hanrahan EO, Lin HY, Kim ES, Yan S, Du DZ, McKee KS, Tran HT, Lee JJ, Ryan AJ, Langmuir P, Johnson BE, Heymach JV. Hanrahan EO, et al. J Clin Oncol. 2010 Jan 10;28(2):193-201. doi: 10.1200/JCO.2009.22.4279. Epub 2009 Nov 30. J Clin Oncol. 2010. PMID: 19949019 Free PMC article. Clinical Trial.

10

Age and associated fibrocystic changes are prognostically significant in patients with small node-negative (T1a,bN0) invasive breast cancer.

Durak MG, Gonzalez-Angulo AM, Hanrahan EO, Broglio KR, Valero V, Hortobagyi GN, Hunt KK, Sahin AA. Durak MG, et al. Among authors: hanrahan eo. Breast J. 2011 Sep-Oct;17(5):462-9. doi: 10.1111/j.1524-4741.2011.01116.x. Epub 2011 Jul 5. Breast J. 2011. PMID: 21726347

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters